Bitcoin’s price continues to consolidate just below the $90K mark after weeks of selling pressure. Buyers are trying to hold the mid-range, but momentum remainsBitcoin’s price continues to consolidate just below the $90K mark after weeks of selling pressure. Buyers are trying to hold the mid-range, but momentum remains

BTC Price Analysis: Key Support Levels to Watch Around $80K

2025/12/20 01:07
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Bitcoin’s price continues to consolidate just below the $90K mark after weeks of selling pressure. Buyers are trying to hold the mid-range, but momentum remains weak across higher timeframes. The current PA (price action) shows signs of temporary relief, but the broader sentiment points to continued caution from institutional players.

Bitcoin Price Analysis: Technicals

By Shayan

The Daily Chart

On the daily chart, BTC is still trading within the descending channel formed over the past couple of months. Both the 100-day and 200-day moving averages are above the price, acting as resistance near $103K and $108K. So far, each bounce attempt has been capped inside the descending channel.

btc_price_chart_1912251Source: TradingView

Key support remains at $80K, which has already been tested twice. If this zone fails, the next major demand lies around $72K. The RSI is also curling upward from oversold, hinting at short-term bullish momentum, but there’s no strong reversal yet.

The 4-Hour Chart

On the 4H chart, BTC broke down from the rising wedge that had formed earlier in December. After sweeping the $90K lows, buyers are attempting to reclaim ground, but the move lacks volume.

The price is trying to establish a local higher low, but the structure still leans bearish. There is a visible rejection near $88K, which was the prior support-turned-resistance. If buyers can’t flip that area soon, another retest of the $80K area will be likely.

The RSI has also recovered from the lows but remains below 60, signaling limited strength. As a result, there is still a high chance of more downside if the BTC does not break back above $90K soon.

btc_price_chart-1912252Source: TradingView

Sentiment Analysis

Bitcoin Coinbase Premium Index

The Coinbase Premium Index remains in negative territory, showing persistent selling pressure from U.S.-based institutions. This divergence has been present throughout the last couple of months and is yet to reverse.

Every local pump has been met with stronger negative premium readings, suggesting that Coinbase whales are offloading into strength. Until this flips back into positive or at least neutral, macro upside remains capped.

Overall, sentiment remains risk-off on the U.S. side, confirming that institutions are not yet ready to re-accumulate aggressively.

sentiment_analysis_chart_191225Source: CryptoQuant

The post BTC Price Analysis: Key Support Levels to Watch Around $80K appeared first on CryptoPotato.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,025.32
$68,025.32$68,025.32
-0.70%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09